Swelling and Scars After Breast Implants Abroad - What It Usually Means

After years of training and work abroad, I have met several patients returning from overseas cosmetic breast surgery. Many of them are unsure of how to manage their recovery.

Case 1 - Haematoma, Seroma, and Missing Operative Notes

One patient had undergone breast augmentation abroad. Unfortunately, she developed a haematoma (postoperative bleeding) after her surgery and required further surgery there before she could return home.

After returning to Singapore, she contacted her overseas clinic about one month post-op. She wanted to check on her scars and was concerned about a possible seroma. The clinic advised her to see a local plastic surgeon to ensure everything was healing properly. This was the right course of action, and that's when she reached out to me.

I asked her to obtain a copy of her operation report, but the clinic declined her request. Without that information, it wasn't immediately clear what had been done or what materials were used. Only later did she mention that fat grafting had also been performed alongside the implants. This detail changes how we interpret the swelling.

After cosmetic breast surgery, fluid can accumulate under the skin. This can occur due to several reasons:

• Leftover blood from earlier bleeding (contained haematoma)

• Inflammation from fat grafting (fat necrosis, oil cysts)

• Normal healing fluid around the implant (seroma)

Most of the time, this fluid settles on its own. However, if swelling persists, it is worth checking early. Occasionally, imaging (usually a bedside ultrasound scan) is needed to confirm that it is simple healing fluid. In rare cases, aspiration may be necessary to rule out other causes, such as infection or breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a lymphoma linked to certain implants, particularly textured ones.

This case also highlights how postoperative bleeding can increase the risk of capsular contracture, and underscores the importance of clear preoperative counselling about such risks for patients undergoing breast augmentation, regardless of where it is performed.

Operative notes are crucial. They belong to the patient and are part of their medical record. They provide essential information about what was done and what materials were used, and guide safe follow-up care regardless of where that care takes place.

What I Often Notice: Scar Placement and Implant Behaviour

Beyond swelling and haematoma, two patterns come up consistently when I review patients after breast augmentation abroad.

(1) Scar placement at the IMF

Several patients have presented with incisions placed directly at the inframammary fold (IMF), the skin crease beneath the breast. Some of these scars also appear indented, suggesting the closure involved tethering to the underlying tissue.

In my opinion, the problem with placing the incision exactly at the fold is that breast implants are expected to descend slightly as they settle over the first few weeks to months. If the scar is at the fold at the time of surgery, it may end up riding upward onto the lower pole of the breast as the implant drops. This becomes visible on the breast itself, rather than hidden within the new, lowered crease. Accounting for this descent when planning the incision position is a straightforward consideration, but one that is not always applied.

(2) Massage instructions: proud or natural?

There is significant variation in the post-operative instructions patients receive. Some are told not to touch or massage the breasts for almost a month, while others are advised to begin gentle massage from day two. Neither is universally right or wrong, but the reasoning behind the instruction matters.

The key question is what the patient wants the implants to feel and behave like. Implants that are kept still and allowed to encapsulate tend to sit higher and more projecting i.e. "proud" on the chest; this position remains even when lying down. Implants that are mobilised early tend to settle into a more natural position, moving slightly to the side when lying flat, as natural breast tissue does. Neither outcome is inherently better, but they are different, and patients should understand which they are being guided toward, and why.

Case 2 - Stitch Abscess, Remote Diagnosis, and a Procedure That Raises Questions

A patient presented with anxiety about her recovery following a "mummy makeover" performed abroad, which had included what she described as a "reduction (lift)" alongside breast implant placement about 3 months ago. She had been diagnosed with a stitch abscess via email and photographs by the overseas clinic, and advised by text message to have the stitch removed and the wound managed with dressings.

On examination, the wound along the vertical limb scar was already healing satisfactorily following a course of antibiotics started by her GP. There was no active infection, no dehiscence, and nothing that warranted the level of anxiety the remote management had generated. A brief in-person assessment resolved in minutes what a week of messaging had failed to.

This is the cost of remote wound management: not always a worse clinical outcome, but reliably a worse patient experience. A photograph cannot replace an examination. A text message cannot reassure a patient the way a clinical review can.

The implant card she brought along raised a separate question entirely however. 205 cc is a modest volume by any standard. The clinical gain from an implant that small is marginal at best. In a post-partum patient with ptotic, deflated breast tissue, introducing the risks and long-term implications of an implant for that degree of augmentation would be hard to justify, at least for me, when alternatives exist.

If the breast tissue was adequate, auto-augmentation mastopexy, using the inferior pole as an internal flap to restore upper pole volume, could potentially have addressed both the ptosis and the deflation without the risks (and costs) of an implant. If adipose tissue was available elsewhere, fat grafting is another option, and in a mummy makeover patient it usually is.

The documented procedure was "reduction (lift)" which raises its own questions. If breast tissue was indeed reduced but then volume replaced with a 205 cc implant, that is circular. If it was a lift only, auto-augmentation or fat grafting could have been considered first. Either way, a small implant in a patient with sufficient native tissue to work with suggests that the surgical planning may not have fully explored what was possible without one. The other risk was that with a potential infection from a stitch abscess, the breast implant may have needed removal had the infection progressed.

Lesson from Case 2: Remote wound assessment has real limitations as a photograph cannot replace an in-person examination, just as a text message cannot replace a clinical consultation. More fundamentally, a small implant placed alongside a mastopexy in a post-partum patient with seemingly adequate breast tissue should prompt the question: was an implant necessary at all?

Case 3 - Periareolar Implants, Seropurulent Discharge, and a Patient Who Had No Idea What Was Done

A patient presented one week after bilateral breast augmentation performed abroad at a cost of $28,000, which had included concurrent axillary liposuction described to her as "complimentary". She had pus-like discharge from the periareolar incision on one side, and firmness in the lower outer quadrant of the other breast with restricted arm elevation, consistent with a contained haematoma.

When asked what her surgeon had done, she was unable to answer. She did not know which plane the implants had been placed in. She did not know why a periareolar approach had been chosen even when she said she preferred an inframammary fold (IMF) incision. The periareolar approach also carries specific risks that are directly relevant to what she was now experiencing. The incision passes through or near the milk ducts, which are not sterile and this increases the risk of bacterial contamination and wound infection compared to an IMF approach. It also carries a higher risk of altered or lost nipple sensation due to the proximity of the nerves. Neither of these risks had been discussed with her. Capsular contracture, the most common long-term complication of breast augmentation, had also not been mentioned, nor was BIA-ALCL. The concurrent axillary liposuction was presented as a "complimentary" addition. She was petite and unlikely to have much of an axillary roll to begin with, so this was most certainly a marketing hook rather than a clinically indicated procedure.

The implants used were presented to her as a top-tier product exclusive to the foreign clinic. On enquiry, they were actually a widely available brand locally at the affordable end of the implant range. The premium pricing was not a reflection of implant quality (this is also a highly contested and debated topic). It was a reflection of marketing.

A course of oral antibiotics was extended for a further week to address the periareolar discharge. She was counselled on what the findings likely represented and what to monitor. She did not return for follow-up. Whether her symptoms resolved is unknown.

That uncertainty is itself the point - a patient one week out from bilateral breast augmentation with active wound discharge and a probable haematoma should have had structured follow-up with her surgeon. She did not, yet still paid for more than what the procedure would have cost if done locally.

Lesson from Case 3: The periareolar approach to breast augmentation carries specific risks such as infection from proximity to the milk ducts, and altered nipple sensation. These must be discussed with the patient before surgery. Incision choice should reflect both clinical judgment and patient preference. A $28,000 procedure that leaves a patient unable to explain what was done to her, with no accessible surgeon when complications arose, and implants marketed as premium but are actually available locally at the affordable end of the range, has not delivered value commensurate with its price.

Takeaway

If you have had breast implants or fat grafting and notice new swelling a few weeks later, don't panic but don't ignore it either. A careful review by a qualified plastic surgeon can help clarify what is happening and ensure your recovery stays on track. Good cosmetic surgery doesn't end when you leave the operating room. It continues with communication, aftercare, and follow-up.

If you have concerns following breast implant surgery abroad, or are considering breast augmentation, you can read more about breast implant complications and breast augmentation. For patients considering mastopexy or breast uplift, you can read more about natural breast lift.

Written by Dr Ng Zhi Yang, UK & Singapore accredited Plastic Surgeon.